» Articles » PMID: 33114511

Ruthenium(IV) Complexes As Potential Inhibitors of Bacterial Biofilm Formation

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Oct 29
PMID 33114511
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

With increasing antimicrobial resistance there is an urgent need for new strategies to control harmful biofilms. In this study, we have investigated the possibility of utilizing ruthenium(IV) complexes (HO)(HL1)[RuCl]·2Cl·2EtOH () and [RuCl(CHCN)](L2)·HO () (where L1-2-hydroxymethylbenzimadazole, L2-1,4-dihydroquinoxaline-2,3-dione) as effective inhibitors for biofilms formation. The biological activities of the compounds were explored using , , PAO1, and LES B58. The new chloride ruthenium complexes were characterized by single-crystal X-ray diffraction analysis, Hirshfeld surface analysis, FT-IR, UV-Vis, magnetic and electrochemical (CV, DPV) measurements, and solution conductivity. In the obtained complexes, the ruthenium(IV) ions possess an octahedral environment. The intermolecular classical and rare weak hydrogen bonds, and π···π stacking interactions significantly contribute to structure stabilization, leading to the formation of a supramolecular assembly. The microbiological tests have shown complex exhibited a slightly higher anti-biofilm activity than that of compound . Interestingly, electrochemical studies have allowed us to determine the relationship between the oxidizing properties of complexes and their biological activity. Probably the mechanism of action of and is associated with generating a cellular response similar to oxidative stress in bacterial cells.

Citing Articles

Chloride and Acetonitrile Ruthenium(IV) Complexes: Crystal Architecture, Chemical Characterization, Antibiofilm Activity, and Bioavailability in Biological Systems.

Jablonska-Wawrzycka A, Rogala P, Czerwonka G, Hodorowicz M, Kalinowska-Tluscik J, Karpiel M Molecules. 2025; 30(3).

PMID: 39942666 PMC: 11820517. DOI: 10.3390/molecules30030564.


Ruthenium Complexes with Pyridazine Carboxylic Acid: Synthesis, Characterization, and Anti-Biofilm Activity.

Rogala P, Jablonska-Wawrzycka A, Czerwonka G, Hodorowicz M, Michalkiewicz S, Kalinowska-Tluscik J Molecules. 2024; 29(23).

PMID: 39683853 PMC: 11643884. DOI: 10.3390/molecules29235694.


Synthesis, Characterization and Biological Investigations of Half-Sandwich Ruthenium(II) Complexes Containing Benzimidazole Moiety.

Rogala P, Jablonska-Wawrzycka A, Czerwonka G, Kazimierczuk K, Galczynska K, Michalkiewicz S Molecules. 2023; 28(1).

PMID: 36615237 PMC: 9821818. DOI: 10.3390/molecules28010040.


Tackling antimicrobial stewardship through synergy and antimicrobial peptides.

Greve J, Cowan J RSC Med Chem. 2022; 13(5):511-521.

PMID: 35694695 PMC: 9132191. DOI: 10.1039/d2md00048b.

References
1.
Wagner V, Iglewski B . P. aeruginosa Biofilms in CF Infection. Clin Rev Allergy Immunol. 2008; 35(3):124-34. DOI: 10.1007/s12016-008-8079-9. View

2.
Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O . Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010; 35(4):322-32. DOI: 10.1016/j.ijantimicag.2009.12.011. View

3.
Priimagi A, Cavallo G, Metrangolo P, Resnati G . The halogen bond in the design of functional supramolecular materials: recent advances. Acc Chem Res. 2013; 46(11):2686-95. PMC: 3835058. DOI: 10.1021/ar400103r. View

4.
Cussac C, Laval F . Reduction of the toxicity and mutagenicity of aziridine in mammalian cells harboring the Escherichia coli fpg gene. Nucleic Acids Res. 1996; 24(9):1742-6. PMC: 145839. DOI: 10.1093/nar/24.9.1742. View

5.
Reiss A, Chifiriuc M, Amzoiu E, Spinu C . Transition Metal(II) Complexes with Cefotaxime-Derived Schiff Base: Synthesis, Characterization, and Antimicrobial Studies. Bioinorg Chem Appl. 2014; 2014:926287. PMC: 3944908. DOI: 10.1155/2014/926287. View